ROKalpha inhibitors (BioFocus)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameROKalpha inhibitors (BioFocus)
Drug Alias NameRho kinase alpha inhibitors (BioFocus)BF-66853BF-66851BF-66852
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsCardiovascular DiseasesErectile DysfunctionGlaucoma +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioFocus DPI
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioFocus DPI
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesErectile DysfunctionGlaucoma +[8] 

Other Information

ATC CodeN/A
Related LinksN/A